Iran Daru Company (DIRAN) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DIRAN
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 16,485,144 | 4,921,438 | 3,986,311 | 3,790,361 | 2,518,087 | 2,214,413 |
| Cost of operating revenue | -6,828,330 | -2,952,863 | -3,028,074 | -2,338,659 | -1,554,877 | -1,168,165 |
| Gross profit (loss) | 9,656,814 | 1,968,575 | 958,237 | 1,451,702 | 963,210 | 1,046,248 |
| Selling, general and administrative expenses | -742,176 | -253,438 | -226,131 | -145,416 | -109,722 | -83,396 |
| Other income | 264,385 | 68,182 | 28,169 | 57,129 | 10,760 | 18,193 |
| Other expenses | -1,066,153 | -2,652 | -4,105 | -46,408 | -3,880 | -22,129 |
| Operating profit (loss) | 8,112,870 | 1,780,667 | 756,170 | 1,317,007 | 860,368 | 958,916 |
| Finance costs | -1,345,389 | -971,014 | -688,923 | -396,173 | -327,256 | -240,522 |
| Other non-operating income and expenses | -576,054 | -535,553 | -62,122 | -17,941 | -3,850 | -9,663 |
| Profit (loss) from continuing operations before tax | 6,191,427 | 274,100 | 5,125 | 902,893 | 529,262 | 708,731 |
| Current year tax | -118,892 | -43,856 | -1,281 | -180,579 | -104,402 | -176,089 |
| Net profit (loss) from continuing operations | 5,220,488 | 130,244 | 3,844 | 722,314 | 424,860 | 532,642 |
| Net profit (loss) | 5,220,488 | 130,244 | 3,844 | 722,314 | 424,860 | 532,642 |
| Basic earnings (loss) per share | 2,963 rials | 156 rials | 4 rials | 826 rials | 486 rials | 633 rials |
| Net earnings (loss) per share, rials | 2,933 rials | 74 rials | 3 rials | 821 rials | 483 rials | 606 rials |
| Capital | 1,780,000 | 1,780,000 | 1,330,000 | 880,000 | 880,000 | 880,000 |
Reporting periods
92 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.